"Swiss Re in conversation about Vivat acquisition"

The Swiss reinsurer Swiss Re is linked to a possible acquisition of Vivat, which is still part of the Chinese group Anbang. The Swiss would discuss this with the Chinese authorities, according to sources, according to the ANP and Bloomberg news agencies

. Swiss Re would be one of the parties approached by Beijing to invest in the troubled Anbang. Chinese society has been hit by financial difficulties, partly because of its own dynamism. A possible takeover of the Belgian insurer Fidea and other European assets would also be discussed. The Swiss, according to sources, have not yet made any decisions

Aegon, ASR and Allianz

A week and a half ago, Vivat confirmed its sale. Rumors about this have been around for a while. Aegon, ASR and Allianz are cited as potential buyers of the Dutch subsidiary of Anbang. This is now Swiss Re.

Anbang has been under Chinese government supervision for more than six months due to poor financial management on the part of General Manager, Wu Xiaohui. He was sentenced to a long prison term.

According to the ANP, the Singaporean sovereign wealth fund Temasek Holdings also held talks with Chinese authorities of interest to Anbang. Temasek already has interests in several major Chinese banks and insurers.